Tissue microarrays of normal tissue and 226 melanocytic lesions (71 banal nevi, 71 in situ and invasive melanomas and 84 metastatic melanomas) were investigated for immunohistochemical expression of CD166, CD133, and nestin. This evidence concerns the gene PROM1 and metastatic melanoma.